Kraematon Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$262K Hold
1,072
0.21% 93
2025
Q4
$222K Buy
+1,072
New +$212K 0.18% 95
2024
Q2
Sell
-1,274
Closed -$202K 89
2024
Q1
$202K Buy
+1,274
New +$203K 0.2% 86
2023
Q4
Sell
-1,472
Closed -$229K 83
2023
Q3
$229K Buy
1,472
+1
+0.1% +$165 0.28% 72
2023
Q2
$243K Buy
1,471
+35
+2% +$5.65K 0.27% 75
2023
Q1
$223K Sell
1,436
-35
-2% -$5.65K 0.26% 75
2022
Q4
$260K Buy
1,471
+1
+0.1% +$173 0.28% 71
2022
Q3
$240K Sell
1,470
-33
-2% -$5.58K 0.31% 74
2022
Q2
$267K Buy
1,503
+2
+0.1% +$356 0.31% 68
2022
Q1
$266K Buy
1,501
+1
+0.1% +$170 0.25% 80
2021
Q4
$257K Buy
+1,500
New +$246K 0.23% 83

Other funds holding JNJ

Kraematon Investment Advisors's JNJ Position: Q1 2026 in Review

Kraematon Investment Advisors held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 1,072 shares worth $262K. The position accounts for 0.21% of the portfolio, ranked #93.

Kraematon Investment Advisors first reported a position in JNJ in Q4 2021 and has held it in 11 quarters since. The position peaked at $267K in Q2 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kraematon Investment Advisors held 1,072 shares of Johnson & Johnson worth $262K as of Q1 2026.
  • Kraematon Investment Advisors left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.21% of Kraematon Investment Advisors's portfolio in Q1 2026, its #93 holding.
  • Kraematon Investment Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 11 quarters since.
  • Kraematon Investment Advisors's Johnson & Johnson position peaked at $267K in Q2 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kraematon Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.